Product image of Moksacin 5 Mg/Ml Kapi (Moxifloxacin Hydrochloride) supplied by GNH India

Moksacin 5 Mg/Ml Kapi

Active Ingredient:
Moxifloxacin Hydrochloride
Origin:
EU

Moksacin 5 Mg/Ml Kapi (Moxifloxacin Hydrochloride)

Moxifloxacin Hydrochloride, the active ingredient in Moksacin 5 Mg/Ml Kapi, is a fluoroquinolone antibiotic presented as a 5 mg/mL eye‑drop solution for ocular use. It treats bacterial conjunctivitis, keratitis and other bacterial ocular infections in patients requiring topical antibacterial therapy.

GNH India supplies Moksacin 5 Mg/Ml Kapi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Jadran-Galenski Laboratorij D.D.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moksacin (moxifloxacin hydrochloride) is used to treat bacterial infections of the eye and related structures.

  • Bacterial conjunctivitis: reduces bacterial load and accelerates symptom resolution.
  • Keratitis: eradicates causative bacteria, promoting corneal healing.
  • Other bacterial ocular infections: provides broad‑spectrum coverage for various bacterial pathogens affecting the eye.

How It Works

  • Moxifloxacin hydrochloride inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By blocking these targets, the drug prevents bacterial cell division and leads to bacterial cell death, delivering a bactericidal effect against susceptible ocular pathogens.

Side Effects

Adverse reactions may occur with ocular use of Moksacin.

Common Side Effects

  • Eye irritation: transient burning or stinging sensation.
  • Redness: mild conjunctival hyperemia.
  • Tearing: increased lacrimation.
  • Foreign‑body sensation: feeling of grit in the eye.
  • Blurred vision: temporary visual disturbance.
  • Pruritus: mild itching of the ocular surface.

Serious or Rare Side Effects

  • Corneal ulceration: rare but severe corneal damage.
  • Anaphylaxis: systemic allergic reaction requiring immediate medical attention.
  • Stevens‑Johnson syndrome: severe mucocutaneous reaction.
  • Toxic keratopathy: damage to corneal epithelium.
  • Persistent visual loss: prolonged or irreversible vision impairment.
  • Endophthalmitis: intra‑ocular infection.

Precautions & Warnings

When prescribing Moksacin, consider the following safety measures.

  • Allergy assessment: avoid use in patients with known hypersensitivity to fluoroquinolones.
  • Contact lens use: discontinue lenses during treatment to reduce irritation risk.
  • Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited.
  • Concomitant ocular drugs: evaluate for possible additive irritation when used with other topical agents.
  • Monitoring: advise patients to report persistent redness, pain, or vision changes promptly.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Moksacin may interact with other ophthalmic agents or systemic medications.

Major Interactions (Avoid)

  • Anticholinergic eye drops: may reduce drug penetration and efficacy.
  • Topical corticosteroids: can mask signs of infection, delaying appropriate therapy.

Moderate Interactions (Monitor Closely)

  • Systemic fluoroquinolones: increased risk of additive toxicity, especially tendon disorders.
  • Non‑steroidal anti‑inflammatory eye drops: may increase ocular irritation.
  • Preservative‑containing solutions: potential for compounded ocular surface toxicity.

Frequently Asked Questions

Moksacin 5 Mg/Ml Kapi is an ophthalmic eye‑drop formulation containing moxifloxacin hydrochloride. It is prescribed to treat bacterial infections of the eye, including bacterial conjunctivitis, keratitis and other bacterial ocular conditions.

Moxifloxacin hydrochloride blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition halts bacterial cell division, leading to a bactericidal effect that clears the infection.

The dosing regimen for Moksacin eye drops is determined by the prescribing clinician based on the specific infection, severity and patient factors. The prescriber will provide the appropriate frequency and duration.

Safety data for moxifloxacin hydrochloride in pregnancy and lactation are limited. It should be used only if the potential benefit outweighs any potential risk to the fetus or infant, and the decision should be made by a qualified health professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moksacin (moxifloxacin) offers broad‑spectrum activity against Gram‑positive and Gram‑negative bacteria and has a higher potency than older fluoroquinolones such as ciprofloxacin. Its once‑daily dosing in many regimens can improve patient compliance compared with agents requiring more frequent administration.

Moksacin should be stored at room temperature, below 25 °C, in its original container. Protect the product from direct light and moisture. Do not freeze, and keep the vial tightly sealed when not in use.

Moksacin is applied topically to the affected eye(s) as directed by the prescriber. Typically, a few drops are instilled into the conjunctival sac, avoiding contact with the eyelid or lashes, and the patient should blink gently to spread the solution.

Serious adverse events, although rare, include corneal ulceration, Stevens‑Johnson syndrome, toxic keratopathy and systemic allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience severe eye pain, vision loss, or systemic allergic symptoms.

Moksacin is contraindicated in individuals with a known hypersensitivity to moxifloxacin, other fluoroquinolones, or any component of the formulation. It should also be avoided in patients with active ocular surface disease where the drug may exacerbate irritation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT